Colgate-Palmolive (NYSE:CL) shares rose premarket Friday after the company reported its latest quarterly earnings, topping consensus expectations.
The consumer products company posted fourth-quarter earnings of $0.87, $0.02 better than the analyst estimate of $0.85. At the same time, revenue for the quarter came in at $4.95 billion, up 7% year-on-year and above the consensus estimate of $4.89 billion.
The company's full-year net sales increased by 8.5% year-on-year, while its full-year EPS was $2.77.
“We are pleased to have finished the year with another quarter of strong top and bottom line results, including 7.0% net and organic sales growth, improved organic volume performance, gross and operating profit margin expansion and double-digit earnings per share growth," said Noel Wallace, CL's CEO.
For the full year 2024, the company sees net sales growth at 1% to 4%, including a low-single-digit negative impact from foreign exchange, while organic sales growth is expected to be within the company's long-term targeted range of 3% to 5%.
Furthermore, CL sees gross profit margin expansion, increased advertising investment and double-digit earnings-per-share growth.
Reacting to the report, analysts at Jefferies said CL reported a strong end to the year with 4Q organic sales and margins topping estimates.
"Sequentially improving volumes and oral care market share gains show the multi-year turnaround plan is working," analysts wrote. "Plans to continue spending more on advertising (+19% in '23) imply management is playing offense. Initial '24 guidance is within algo, and beatable, in our view."
What is the average analyst price target on CL? Find out with InvestingPro. For an extra 10% discount, use Coupon: Canada2024.
Don’t miss the New Year’s sale, for up to 60% off. Only until Jan 31.